Korean Market
OWNR
Curocell
★

Executive Park Jin-kyung purchases 1,000 additional shares of Curocell… ownership ratio drops to 2.91% due to dilution

 
OWNR
Curocell
★

Curocell's Largest Shareholder Gunsu Kim Sees Stake Drop to 29.32% Due to Share Increase Despite Insider Buying, Raising Dilution Risk

 
OTHR
Curocell
★

Curocell Grants 114,300 Stock Options to 85 Employees... Exercise Price at Premium Limits Dilution Concerns

 
EXCH
Curocell
★

Curocell Submits Amendment to Phase 1/2 Clinical Trial Plan for CRC01 in SLE, Modifying Primary Endpoint

 
EXCH
Curocell
★

Disclosure of 36.3 Billion Won Third-Party Allotment Convertible Preferred Share Issuance Result

 
EXCH
Curocell
★

Completion of 4th Unsecured Private Convertible Bond Issuance of KRW 36.35 Billion

 
EXCH
Curocell
★★★★

MFDS Approves CAR-T Therapy 'Rimcato' for Relapsed DLBCL and PMBCL

 
OWNR
Curocell
★

Submission of Report on Ownership of Specific Securities by Executives and Major Shareholders

 
PERI
Curocell
★★★

Curocell Obtains MFDS Approval for CAR-T Therapy Rimqarto and Raises 72.6 Billion KRW

 
OWNR
Curocell
★

Filing of Large Shareholding Report for Simple Investment Purpose (Mirae Asset Capital et al.)